Procurement Summary
Country : Germany
Summary : Open House Contracts for Multiple Active Ingredients/Active Ingredient Combinations
Deadline : 07 Oct 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 73747252
Document Ref. No. : 594454-2022
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of this publication is the conclusion of contracts in accordance with § 130a Para. 8 SGB V for the following active ingredients/combinations of active ingredients as part of a so-called open house procedure:
Aprepitant (A04AD12) only packs with one component other than the 80mg N1 form
Bimatoprost ( S01EE03)
Budesonid (A07EA06, D07AC09, R01AD05, R03BA02) ohne Inhalativa
Clonazepam (N03AE01)
Eisen(II)sulfat (B03AA07)
Emtricitabin/Tenofovirdisoproxil/Rilpivirin (J05AR08)
Hydroxychloroquin (P01BA02)
Lenograstim (L03AA10)
Nadroparin (B01AB06)
Vildagliptinnditions and a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the opportunity to conclude a discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredients/active ingredient combinations mentioned.
DeThe earliest start of the contract is December 1st, 2022. Based on this, the contract period is a maximum of 24 months.
Doc Title: Pharmaceutical products
Contract Type: Supplies
Document Type : Contract notice
Reference Number : 2022-10-24-NW-DRA-Open House
Contract Type : Supplies
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2022-10-24
Publish Date : 2022-10-28
Submission Date : 2024-10-07
Documents
Tender Notice